Closure of the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis

Page last updated: 21 December 2020

A plain language summary for the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis is now available.

In addition the webpage has been updated to include:

• A link to the public summary document (PSD) for the cost-effectiveness review of the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis; and
• The Review Report has now been published as final with no changes made from the previously published draft Review Report.

These documents can be accessed from the Review webpage.